InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Explore the full record of transactions filed by Menold Daniel. Officer active across 1 company, notably CymaBay Therapeutics, Inc.. Cumulatively, 7 filings have been published. History available since 9 August 2023. The latest transaction was disclosed on 16 January 2024 (Levée d'options). Regulator: SEC (Form 4). The full history is openly available.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
7 of 7 declarations
Menold Daniel is Vice President, Finance at CymaBay Therapeutics, Inc. He has 7 filings in total, and across the 7 sampled filings the period runs from 2023-08-11 to 2024-01-16, with Levée d'options as the modal transaction nature.